| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.014 | 0.8 |